| Date Filed | Type | Description |
| 06/12/2023 |
4
| Iwicki Mark T (Director) has filed a Form 4 on Merus N.V.|
Txns:
| Granted 14,414 options to buy
@ $23.29, valued at
$335.7k
|
|
| 06/08/2023 |
4
| Iwicki Mark T (Director) has filed a Form 4 on Aerovate Therapeutics, Inc.|
Txns:
| Granted 12,500 options to buy
@ $16.3, valued at
$203.8k
|
|
| 06/08/2023 |
4
| Iwicki Mark T (Director) has filed a Form 4 on Third Harmonic Bio, Inc.|
Txns:
| Granted 16,250 options to buy
@ $5.03, valued at
$81.7k
|
|
| 06/02/2023 |
4
| Iwicki Mark T (CEO) has filed a Form 4 on Kala Pharmaceuticals, Inc.|
Txns:
| Granted 71,715 shares
@ $0
Disposed/sold 5,449 options to buy
@ $0
Disposed/sold 7,576 options to buy
@ $0
Disposed/sold 12,195 options to buy
@ $0
Disposed/sold 1,572 options to buy
@ $0
Disposed/sold 4,599 options to buy
@ $0
Disposed/sold 9,199 options to buy
@ $0
Disposed/sold 7,299 options to buy
@ $0
Disposed/sold 6,059 options to buy
@ $0
Disposed/sold 15,499 options to buy
@ $0
Disposed/sold 2,268 options to buy
@ $0 |
|
| 04/17/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/15/2023 |
4
| Iwicki Mark T (CEO) has filed a Form 4 on Kala Pharmaceuticals, Inc.|
Txns:
| Granted 1,512 options to buy
@ $68.5, valued at
$103.6k
|
|
| 03/08/2023 |
4
| Iwicki Mark T (Director) has filed a Form 4 on Third Harmonic Bio, Inc.|
Txns:
| Disposed/sold 35,413 options to buy
@ $9.22, valued at
$326.5k
Granted 35,413 options to buy
@ $4.2, valued at
$148.7k
Disposed/sold 13,667 options to buy
@ $17.83, valued at
$243.7k
Granted 13,667 options to buy
@ $4.2, valued at
$57.4k
|
|
| 01/06/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/28/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/27/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/14/2022 |
3
| Iwicki Mark T (Director) has filed a Form 3 on Third Harmonic Bio, Inc. |
| 06/29/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/22/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/03/2022 |
4
| Iwicki Mark T (Director) has filed a Form 4 on Akero Therapeutics, Inc.|
Txns:
| Granted 15,000 options to buy
@ $8.13, valued at
$122k
|
|
| 06/02/2022 |
4
| Iwicki Mark T (Director) has filed a Form 4 on Merus N.V.|
Txns:
| Granted 16,604 options to buy
@ $18.56, valued at
$308.2k
|
|
| 01/05/2022 |
4
| Iwicki Mark T (CEO) has filed a Form 4 on Kala Pharmaceuticals, Inc.|
Txns:
| Sold 9,518 shares
@ $1.3, valued at
$12.4k
Granted 775,000 options to buy
@ $1.37, valued at
$1.1M
|
|
| 10/28/2021 |
4
| Iwicki Mark T (CEO) has filed a Form 4 on Kala Pharmaceuticals, Inc.|
Txns:
| Sold 27,598 shares
@ $1.8, valued at
$49.7k
|
|
| 07/01/2021 |
4
| Iwicki Mark T (Director) has filed a Form 4 on Aerovate Therapeutics, Inc.|
Txns:
| Granted 39,550 options to buy
@ $0
Granted 76,747 options to buy
@ $0
Granted 42,200 options to buy
@ $14, valued at
$590.8k
|
|
| 06/29/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 06/29/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/03/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/02/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/01/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/05/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/28/2020 |
4
| Iwicki Mark T (CEO) has filed a Form 4 on Kala Pharmaceuticals, Inc.|
Txns:
| Granted 178,300 shares
@ $0 |
|
| 10/14/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/02/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/29/2020 |
4
| Iwicki Mark T (CEO) has filed a Form 4 on Kala Pharmaceuticals, Inc.|
Txns:
| Granted 49,560 shares
@ $0 |
|
| 06/02/2020 |
4
| Iwicki Mark T (Director) has filed a Form 4 on Akero Therapeutics, Inc.|
Txns:
| Granted 13,000 options to buy
@ $25.2, valued at
$327.6k
|
|
| 05/29/2020 |
4
| Iwicki Mark T (Director) has filed a Form 4 on Aimmune Therapeutics, Inc.|
Txns:
| Granted 7,840 shares
@ $0
Granted 15,398 options to buy
@ $17.11, valued at
$263.5k
|
|
| 04/06/2020 |
4
| Iwicki Mark T (Director) has filed a Form 4 on Pulmatrix, Inc.|
Txns:
| Granted 10,000 options to buy
@ $1.28, valued at
$12.8k
|
|
| 01/13/2020 |
4
| Iwicki Mark T (Director) has filed a Form 4 on Pulmatrix, Inc.|
Txns:
| Granted 15,000 options to buy
@ $1.54, valued at
$23.1k
|
|
| 01/03/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/02/2020 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
|